drugset / Trial / NCT02359695

Low-dose GH Supplementation Increases Clinical Pregnancy Rate

NCT02359695

Phase 1 Completed 64 enrolled Centro de Infertilidad y Reproducción Humana
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to assess whether a low dose of GH supplementation (0.5 IU/day) increases clinical pregnancy rates in women with a history of POR who failed to become pregnant in two previous IVF cycles.

Timeline

Start
2013-10
Primary completion
2016-12
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.5 iu

Indications